tirzepatide manufacturer eli lilly People with diabetes lost up to 34 pounds taking drug, company says Eli Lilly sold $176 million

This reluctance is likely to be at least partially attributable to the fact that, until recently, all GLP-1RAs were available as subcutaneous (s.c.) injections, given twice daily (exenatide [13]), once daily (lixisenatide [14] and liraglutide [15]), or once weekly (semaglutide [16], dulaglutide [17], and exenatide extended release [18]), a route that may be less preferable to some patients compared with oral administration [1, 19]

Purification and characterisation of a microbial L-carnitine amidase [PMID: 7764422] Laboratory literature summary: Purification and characterisation of a microbial L-carnitine amidase

Essink-Bot, M

2.5 mg/mL or 5 mg/mL)

10.1016/j.cbi.2019.05.006 Chem Biol Interact